News
A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...
OpenAI and the U.S. Food and Drug Administration have been meeting to discuss the health regulator's use of AI, technology ...
Recent actions by President Donald Trump's administration, including staff cuts at the Food and Drug Administration, have ...
The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...
A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...
WEDNESDAY, May 7, 2025 (HealthDay News) — The official in charge of federal food and drug safety inspections will retire May ...
Dr. Vinay Prasad was an outspoken critic of the FDA’s response to the pandemic, including the former vaccine chief, Dr. Peter ...
WEDNESDAY, May 7, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has chosen Dr. Vinay Prasad, a ...
WASHINGTON (AP) — Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, ...
High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT ...
GlobalData on MSN9h
FDA plans to expand unannounced inspections of foreign drug plantsThis move comes a day after President Trump signed an executive order to streamline approval processes for domestic plants.
OpenAI has reportedly met with officials from the Food and Drug Administration to discuss how AI could speed up drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results